What is the recommended dosage of Levepil (Levetiracetam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Levetiracetam (Levepil)

The recommended dosage of Levetiracetam (Levepil) for adults with partial onset seizures is 1000 mg/day initially (500 mg twice daily), which can be increased by 1000 mg/day every 2 weeks to a maximum recommended daily dose of 3000 mg. 1

Adult Dosing

Partial Onset Seizures (Adults 16 Years and Older)

  • Initial dose: 1000 mg/day, given as twice-daily dosing (500 mg BID) 1
  • Titration: Additional dosing increments of 1000 mg/day every 2 weeks 1
  • Maximum recommended daily dose: 3000 mg 1
  • Administration: Can be given orally with or without food 1

Myoclonic Seizures (12 Years and Older with Juvenile Myoclonic Epilepsy)

  • Initial dose: 1000 mg/day, given as twice-daily dosing (500 mg BID) 1
  • Titration: Increase by 1000 mg/day every 2 weeks 1
  • Recommended daily dose: 3000 mg 1

Primary Generalized Tonic-Clonic Seizures (Adults 16 Years and Older)

  • Initial dose: 1000 mg/day, given as twice-daily dosing (500 mg BID) 1
  • Titration: Increase by 1000 mg/day every 2 weeks 1
  • Recommended daily dose: 3000 mg 1

Pediatric Dosing

Partial Onset Seizures (Ages 4 to <16 Years)

  • Initial dose: 20 mg/kg/day in 2 divided doses (10 mg/kg BID) 1
  • Titration: Increase by 20 mg/kg every 2 weeks 1
  • Recommended daily dose: 60 mg/kg/day (30 mg/kg BID) 1
  • For patients who cannot tolerate 60 mg/kg/day, the dose may be reduced 1

Primary Generalized Tonic-Clonic Seizures (Ages 6 to <16 Years)

  • Initial dose: 20 mg/kg/day in 2 divided doses (10 mg/kg BID) 1
  • Titration: Increase by 20 mg/kg every 2 weeks 1
  • Recommended daily dose: 60 mg/kg/day (30 mg/kg BID) 1

Special Clinical Scenarios

Status Epilepticus

  • For non-convulsive status epilepticus: Loading dose of 40 mg/kg (maximum 2,500 mg) IV bolus, followed by maintenance dose of 15 mg/kg (maximum 1,500 mg) IV every 12 hours 2
  • For convulsive status epilepticus: Loading dose of 40 mg/kg (maximum 2,500 mg) IV bolus, followed by maintenance dose of 30 mg/kg IV every 12 hours or increase prophylaxis dose by 10 mg/kg to 20 mg/kg IV every 12 hours (maximum 1,500 mg) 2

Neurocritical Care (Seizure Prophylaxis)

  • Higher doses (>1000 mg total daily dose, typically 1000 mg twice daily) may be more effective for seizure prophylaxis in patients with subarachnoid hemorrhage or traumatic brain injury 3
  • Standard dose of 500 mg twice daily may be associated with higher seizure incidence compared to 1000 mg twice daily in these patients 3

Busulfan-Induced Seizure Prevention

  • Adults: 500-1000 mg twice daily 4
  • Children: 10 mg/kg twice daily (20 mg/kg/day in 2 divided doses) 4
  • Start 6-24 hours before busulfan initiation and continue until 24-48 hours after the last dose 4

Oral Loading

  • In situations requiring rapid initiation, oral loading with 1500 mg as a single dose has been shown to be well-tolerated 5
  • Maintenance dosing can begin 12 hours later at 500-1000 mg twice daily 5

Important Considerations

  • Levetiracetam has a broad therapeutic window and predictable pharmacokinetics 6
  • Routine therapeutic drug monitoring is generally not recommended 6
  • No clinically relevant drug interactions have been observed with other anticonvulsants, digoxin, warfarin, or oral contraceptives 7
  • Common side effects include somnolence, asthenia, headache, and dizziness 7

Levetiracetam has shown efficacy as both monotherapy and adjunctive therapy, with equivalent seizure freedom rates compared to controlled-release carbamazepine in newly diagnosed epilepsy 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.